Indeed, maxacalcitol is as effective as calcitriol in suppressing PTH in patients on chronic HD [41], but a report demonstrated that intravenous maxacalcitol therapy in chronic HD patients markedly improved bone histology, without a decrease in PTH levels [42]. The gene discussed is PTH; the disease is Huntington disease.